You are here: Industry Insights > CytoSorbents

News List

CytoSorbents Completes its Mission 100,000 International Fundraising Campaign to Fight the Spread of COVID-19 for Global Humanitarian Organization, CARE prnewswire
August 02, 2021
CytoSorbents Corporation announces the successful completion of its MISSION 100,000 international fundraising campaign to fight the spread of COVID-19, raising $100,000 to benefit the global, not-for-profit humanitarian organization, CARE.
CytoSorbents Announces Approval of CytoSorb® in Korea in Collaboration with Partner Fresenius Medical Care prnasia
January 21, 2021
CytoSorbents Corporation, a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients around the world, announces that the Korean Ministry ...
FDA Grants CytoSorb Emergency Use Authorization for COVID-19 Patients americanpharmaceuticalreview
April 15, 2020
CytoSorbents announced the United States Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) of CytoSorb® for use in patients with COVID-19 infection.
CytoSorbents Enrolls First Patient into Pivotal U.S. REFRESH 2-AKI Trial Using CytoSorb® During Complex Cardiac Surgery biospace
April 25, 2018
CytoSorbents Corporation announced first patient enrollment into the pivotal U.S. REFRESH 2-AKI trial.